X4 Pharmaceuticals Inc.
XFOR | NASDAQ
$3.42
-$0.08 (-2.15%)
Sep 22, 2026, 12:30 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 217.05M | 55.7M | 99.22M | 121.72M | 81.79M | 78.97M |
Short-Term Investments | 35.95M | 46.36M | 15M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 1.32M | 1.73M |
Other Long-Term Assets | 692K | 2.08M | 1.44M | 1.23M | 402K | 1.53M |
Receivables | 573K | 1.71M | 562K | 1.15M | 747K | 917K |
Inventory | 4.48M | 2.82M | n/a | n/a | n/a | n/a |
Other Current Assets | 3.53M | 5.59M | 7.3M | 5.81M | 5.34M | 3.42M |
Total Current Assets | 261.58M | 112.18M | 122.08M | 128.68M | 87.88M | 83.31M |
Property-Plant & Equipment | 1.59M | 4.84M | 6.4M | 8.33M | 10.22M | 9.2M |
Goodwill & Intangibles | 26.6M | 27.35M | 17.35M | 17.35M | 17.35M | 27.11M |
Total Long-Term Assets | 28.88M | 34.27M | 25.18M | 26.91M | 29.3M | 39.56M |
Total Assets | 290.46M | 146.45M | 147.26M | 155.59M | 117.18M | 122.87M |
Account Payables | 5.7M | 8.62M | 8.95M | 7.78M | 4.28M | 3.14M |
Deferred Revenue | 464K | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 1.32M | 1.87M | 786K |
Other Current Liabilities | 4.3M | 13.05M | 8.2M | 6.59M | 2.45M | 4.26M |
Total Current Liabilities | 25.76M | 32.88M | 22.86M | 22.32M | 14.02M | 11.95M |
Long-Term Debt | 76.29M | 75.43M | 54.57M | 32.3M | 33.14M | 33.18M |
Other Long-Term Liabilities | 1.5M | 14.59M | 16.12M | 23.3M | 826K | 462K |
Total Long-Term Liabilities | 78.41M | 91.42M | 73.3M | 59.21M | 38.74M | 38.12M |
Total Liabilities | 104.17M | 124.3M | 96.16M | 81.54M | 52.76M | 50.07M |
Total Debt | 77.29M | 78.09M | 58.28M | 38.42M | 39.79M | 38.45M |
Book Value | 186.29M | 22.15M | 51.1M | 74.05M | 64.41M | 72.8M |
Book Value Per Share | 4.40 | 3.30 | 8.62 | 34.97 | 75.05 | 108.78 |
Common Stock | 91K | 6K | 167K | 122K | 28K | 16K |
Retained Earnings | -594.55M | -515.36M | -477.91M | -376.74M | -282.87M | -194.18M |
Comprehensive Income | -109K | -122K | -119K | -119K | -119K | -119K |
Shareholders Equity | 186.29M | 22.15M | 51.1M | 74.05M | 64.41M | 72.8M |
Total Investments | 35.95M | 46.36M | 15M | n/a | 1.32M | 1.73M |
Add to Watchlist
Select watchlists to add or remove XFOR